Status:
COMPLETED
Outcome of MC3 Ring Annuloplasty for Functional Tricuspid Regurgitation
Lead Sponsor:
Minia University
Conditions:
Functional Tricuspid Regurgitation
Eligibility:
All Genders
18-80 years
Brief Summary
This study includes 105 patients who underwent repair for ≥ moderate tricuspid regurgitation (TR) during mitral valve replacement for rheumatic valve disease. Between January 2016 and December 2018, a...
Detailed Description
This study evaluated early and midterm outcomes after operations for TV repair which were performed at our institution, between January 2016 and December 2018. The mean follow-up duration was 18.84±9....
Eligibility Criteria
Inclusion
- Rheumatic mitral valve disease
- Surgery for mitral valve replacement
- Severe functional tricuspid regurgitation
- Moderate functional tricuspid regurgitation with annular dilatation \> 40 mm
- Moderate functional tricuspid regurgitation with preoperative systolic pulmonary artery pressure (SPAP) \>50 mmHg
Exclusion
- Patients with non-rheumatic mitral disease
- Combined mitral and aortic valve replacement
- Mitral valve repair
- Concomitant coronary artery or aortic surgery
- Mild or organic tricuspid regurgitation
- Emergency surgery
- Reoperations
- Invalid or missed data
Key Trial Info
Start Date :
January 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2018
Estimated Enrollment :
105 Patients enrolled
Trial Details
Trial ID
NCT04078867
Start Date
January 1 2016
End Date
December 31 2018
Last Update
September 6 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.